Reaction of a Phenyl-Substituted Cyclopentadienyl Cation
to afford 5 (0.256 g, 88%) as pale yellow crystals: mp 153-154
°C; 1H NMR (300 MHz, C6D6) δ 7.60 (d, J ) 7.5 Hz, 2H),
7.31-7.23 (m, 2H), 3.16 (br s, 1H), 2.94-2.82 (m, 2H), 2.77 (br
s, 1H), 2.64 (d, J ) 13.8 Hz, 1H), 2.37 (t, J ) 5.9 Hz, 1H),
1.94-1.38 (m, 20H), 1.32 (d, J ) 12.3 Hz, 1H), 1.11 (d, J ) 14.4
Hz, 1H), one of the phenyl proton signals was overlapped with the
solvent peak; 13C NMR (75 MHz, C6D6) δ 150.6, 147.7, 146.0,
140.2, 136.7, 130.9 (2C), 128.8 (2C), 127.6, 89.0, 44.7, 38.3, 37.8,
37.2, 36.4, 36.3, 36.13, 36.07, 33.8, 32.7, 31.6, 30.9 (2C), 30.2,
28.6, 28.5, 28.2, 27.8; IR (KBr, cm-1) 2906, 2848, 1489, 1465,
1440, 1084, 946, 823, 781, 695. Anal. Calcd for C29H33Cl: C, 83.52;
H, 7.98. Found: C, 83.59; H, 7.95.
(B) Preparation with Chloride 5 and Ag+(C6H6)3B(C6F5)4-. An
NMR sample tube containing chloride 5 (23.5 mg, 0.056 mmol)
and Ag+(C6H6)3B(C6F5)4- 22 (58.4 mg, 0.057 mmol) was evacuated
with a vacuum line. CD2Cl2 (0.75 mL), dried over CaH2 and
degassed by repeated freeze-pump-thaw cycles, was vacuum-
transferred to the NMR sample tube, which was then sealed under
1
vacuum. The reaction mixture was monitored at -80 °C by H
and 13C NMR, which showed the quantitative formation of cation
8+.
(C) Preparation with Cyclopentadienol 7 and B(C6F5)3. An
NMR sample tube containing alcohol 7 (38.2 mg, 0.096 mmol)
and B(C6F5)3 (51.5 mg, 0.101 mmol) was evacuated with a vacuum
line. CD2Cl2 (0.75 mL), dried over CaH2 and degassed by repeated
freeze-pump-thaw cycles, was vacuum-transferred to an NMR
sample tube, which was then sealed under vacuum. The reaction
mixture was stirred at -78 °C for 30 min and monitored at -90
°C by 1H and 13C NMR, which showed the quantitative formation
of the cation 8+.
Methoxycyclopentadiene 6. A solution of chlorocyclopentadiene
5 (14.1 mg, 0.034 mmol) in MeOH (2 mL) was stirred under N2
for 24 h. Water (100 mL) was added, and the mixture was extracted
with CH2Cl2. The organic layer was washed with 5% NaHCO3 and
10% NaCl and dried (MgSO4). The solvent was evaporated, and
the residue purified by column chromatography on SiO2 using
CH2Cl-hexane as the eluent to afford 6 (11.4 mg, 81%) as pale
-
MeOH Quenching of 8+SbF6 to Form 14. Chloride 5 (35.6
1
yellow crystals (prisms): mp 179-180 °C; H NMR (300 MHz,
mg, 0.085 mmol) was allowed to react with AgSbF6 (31.4 mg, 0.091
mmol) in dry CH2Cl2 (1.5 mL) for 10 min at -78 °C and for a
further 30 min at room temperature. The solution was cooled again
to -78 °C, and dry MeOH (1.0 mL) was added dropwise over 5
min. The mixture was warmed to room temperature, stirred for 30
min, and filtered through a PTFE membrane filter to remove the
AgCl. Water (50 mL) was added, and the mixture was extracted
with CH2Cl2. The organic layer was dried (MgSO4) and evaporated.
The residue was purified by chromatography on SiO2 to give 14
(29.2 mg, 83% based on 5) as colorless crystals: mp 139-140 °C;
1H NMR (300 MHz, C6D6) δ 7.34 (d, J ) 8.3 Hz, 2H), 7.27 (t, J
) 7.5 Hz, 2H), 3.29 (dt, J ) 12.6, 2.6 Hz, 1H), 3.12-2.97 (m,
4H), 2.55 (s, 3H), 2.14-1.36 (m, 23H), one of the phenyl proton
signals was overlapped with the solvent peak; 13C NMR (75 MHz,
C6D6) δ 148.5, 147.1, 145.5, 143.2, 140.5, 130.5, 128.0, 126.2,
82.2, 65.5, 55.8, 42.4, 41.9, 39.7, 38.2, 38.0, 37.8, 37.5, 37.0, 36.5,
C6D6) δ 7.55 (d, J ) 8.0 Hz, 2H), 7.28 (t, J ) 7.8 Hz, 2H), 7.09
(d, J ) 7.5 Hz, 1H), 3.32-3.24 (m, 1H), 3.27 (s, 3H), 3.10-2.94
(m, 2H), 2.82 (t, J ) 5.7 Hz, 1H), 2.32 (t, J ) 5.6 Hz, 1H), 2.21
(d, J ) 13.5 Hz, 1H), 2.04-1.44 (m, 20H), 1.39 (d, J ) 12.0 Hz,
1H), 1.16 (d, J ) 13.5 Hz, 1H); 13C NMR (75 MHz, C6D6) 152.7,
147.9, 142.6, 137.6, 135.5, 128.9 (2C), 128.8 (2C), 126.8, 95.8,
49.9, 44.2, 38.6, 38.5, 37.8, 37.6, 36.3, 36.1, 34.0, 32.7, 32.6, 31.5,
31.02, 30.99, 30.95, 29.3, 28.5, 28.3, 28.2; IR (KBr, cm-1) 2898,
2843, 1598, 1489, 1464, 1442, 1073, 942, 762, 700. Anal. Calcd
for C30H36O: C, 87.33; H, 8.79. Found: C, 87.08; H, 8.79.
Cyclopentadienol 7. Crude chloride 5, prepared from cyclo-
pentadiene 4 (0.372 g, 0.97 mmol) and N-chlorosuccinimide (0.142
g, 1.06 mmol) by the method described above, was passed through
a silica gel column using hexane-CH2Cl2 as an eluent. The solvent
was removed by evaporation, and the residue was recrystallized
from CH2Cl2-MeCN (1:1) to afford 7 (0.261 g, 67% based on 4)
as colorless crystals: mp 192-193 °C; 1H NMR (300 MHz, C6D6)
δ 7.59 (d, J ) 8.1 Hz, 2H), 7.26 (t, J ) 7.5 Hz, 2H), 7.11 (t, J )
7.4 Hz, 1H), 3.13 (t, J ) 5.3 Hz, 1H), 3.05 (br s, 1H), 2.91 (d, J
) 13.2 Hz, 1H), 2.78 (t, J ) 5.6 Hz, 1H), 2.46-2.28 (m, 2H),
2.04-1.45 (m, 20H), 1.38 (d, J ) 10.5 Hz, 1H), 1.32 (s, 1H), 1.13
(d, J ) 14.1 Hz, 1H); 13C NMR (75 MHz, C6D6) δ 150.0, 147.7,
145.3, 140.8, 137.6, 129.5 (2C), 126.9, 91.7, 44.2, 38.3, 38.0, 37.9,
37.0, 36.6, 36.2, 33.2, 32.8, 32.6, 31.33, 31.27, 30.9, 30.8, 29.0,
28.5, 28.3, 28.2, one of the phenyl carbon signals was overlapped
with the solvent peak; IR (KBr, cm-1) 2903, 2841, 1491, 1440,
1348, 991, 943, 701. Anal. Calcd for C29H34O: C, 87.39; H, 8.60.
Found: C, 87.30; H, 8.65.
34.9, 32.2, 31.8, 30.82, 30.77, 29.6, 29.0, 28.4; IR (KBr, cm-1
)
2907, 2876, 2843, 1493, 1441, 1092, 1077, 1064, 959, 934, 799,
754, 744, 700. HRMS (EI+) m/z calcd for C30H36O (M+) 412.2766,
found 412.2774.
X-ray Crystal Structure Analysis. Intensity data were collected
at 100 K on a Bruker SMART APEX diffractometer with Mo KR
radiation (λ ) 0.71073 Å) and graphite monochromator. The
structures were solved by direct method (SHELXTL) and refined
by the full-matrix least-squares on F2 (SHELXL-97). All non-
hydrogen atoms were refined anisotropically, and hydrogen atoms
were placed using AFIX instructions and refined isotropically.
4: C29H34; FW ) 382.56, crystal size 0.10 × 0.10 × 0.10 mm3,
monoclinic, P2(1)/n, a ) 6.3533(12) Å, b ) 17.527(3) Å, c )
18.820(4) Å, ꢀ ) 96.512(4)°, V ) 2082.2(7) Å3, Z ) 4, Dc )
1.220 g cm-3. The refinement converged to R1 ) 0.0528, wR2 )
0.1067 (I > 2σ(I)), GOF ) 1.013.
5: C29H33Cl; FW ) 417.00, crystal size 0.20 × 0.20 × 0.20
mm3, triclinic, P-1, a ) 6.5347(13) Å, b ) 10.784(2) Å, c )
15.777(3) Å, R ) 74.790(4)°, ꢀ ) 82.116(4)°, γ ) 81.619(4)°, V
) 1055.7(4) Å3, Z ) 2, Dc ) 1.312 g cm-3. The refinement
converged to R1 ) 0.0406, wR2 ) 0.0869 (I > 2σ(I)), GOF ) 1.082.
6: C30H36O; FW ) 412.59, crystal size 0.20 × 0.20 × 0.20 mm3,
monoclinic, C2/c, a ) 11.0557(16) Å, b ) 17.650(3) Å, c )
22.609(3) Å, ꢀ ) 97.847(3)°, V ) 4370.6(11) Å3, Z ) 8, Dc )
1.254 g cm-3. The refinement converged to R1 ) 0.0429, wR2 )
0.0857 (I > 2σ(I)), GOF ) 1.012.
Preparation and Characterization of Cation 8+. (A)
Preparation with Chloride 5 and AgSbF6. An NMR sample tube
containing chloride 5 (16.6 mg, 0.040 mmol) and AgSbF6 (14.4
mg, 0.042 mmol) was evacuated with a vacuum line. CD2Cl2 (0.75
mL), dried over CaH2 and degassed by repeated freeze-pump-thaw
cycles, was vacuum-transferred to the NMR sample tube, which
was then sealed under vacuum. The reaction mixture was warmed
1
to room temperature and monitored by H and 13C NMR, which
showed the quantitative formation of cation 8+. Reddish orange
-
crystals of 8+SbF6 suitable for X-ray analysis were obtained by
allowing the reaction mixture to stand at room temperature for 1
1
week: mp 240 °C dec; H NMR (300 MHz, CD2Cl2, rt) δ 7.72 (t,
J ) 7.4 Hz, 1H), 7.64 (t, J ) 7.2 Hz, 2H), 7.43 (d, J ) 6.9 Hz,
2H), 4.15 (d, J ) 5.4 Hz, 1H), 3.54 (t, J ) 5.6 Hz, 1H), 3.30 (t, J
) 5.7 Hz, 1H), 3.13 (br s, 1H), 2.50 (dtd, J ) 18.5, 6.5, 1.7 Hz,
1H), 2.40-1.55 (m, 22H), 1.42 (d, J ) 13.2 Hz, 1H); 13C NMR
(75 MHz, CD2Cl2, rt) δ 241.2, 210.5, 155.4, 135.4, 132.6, 130.3
(2C), 129.9 (2C), 119.6, 68.2, 61.5, 40.0, 38.03, 37.99, 36.5, 35.0,
34.3, 33.2 (2C), 32.4, 32.3, 30.8, 30.2, 28.8, 28.3, 27.3, 26.7, 26.5;
IR (KBr, cm-1) 2903, 1456, 1449, 1437, 1232, 937, 657; UV-vis
(CH2Cl2) λmax (ꢀ) 327 (6720), 373 (8090), 459 (7170).
8+SbF6-: C29H33F6Sb; FW ) 617.30, crystal size 0.10 × 0.10
× 0.10 mm3, monoclinic, P2(1)/n, a ) 10.0120(13) Å, b )
21.486(3) Å, c ) 11.6831(16) Å, ꢀ ) 100.848(2)°, V ) 2468.3(6)
Å3, Z ) 4, Dc ) 1.661 g cm-3. The refinement converged to R1 )
0.0378, wR2 ) 0.0726 (I > 2σ(I)), GOF ) 1.061.
14: C30H36O; FW ) 412.59, crystal size 0.10 × 0.10 × 0.10
mm3, monoclinic, P2(1)/c, a ) 16.001(2) Å, b ) 9.9744(14) Å, c
) 14.124(2) Å, ꢀ ) 95.655(3)°, V ) 2243.3(6) Å3, Z ) 4, Dc )
J. Org. Chem. Vol. 73, No. 14, 2008 5253